Search research articles
Contact Us
Filters
Showing results (151-160 of 184) with videos related to
Page
of 19
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1992
Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity
K B Johnson, H E Criswell, K F Jensen, et al.
Annals of Emergency Medicine
|
September 11, 1992
Selective aortic arch perfusion during cardiac arrest: a new resuscitation technique
J E Manning, C A Murphy, C M Hertz, et al.
Journal of Neurochemistry
|
November 1, 1987
Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression
S P Sivam, G R Breese, J E Krause, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1985
Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation
G E Duncan, I A Paul, T K Harden, et al.
Psychopharmacology
|
January 1, 1980
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function
G D Frye, G R Breese, R B Mailman, et al.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1984
Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome
G R Breese, A A Baumeister, T J McCown, et al.
Psychopharmacology
|
January 1, 1981
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity
M G Ondrusek, C D Kilts, G D Frye, et al.
Brain Research
|
April 14, 1978
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons
R J Konkol, R B Mailman, E G Bendeich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1987
6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding
G R Breese, G E Duncan, T C Napier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1983
Pharmacokinetics of methylphenidate in man, rat and monkey
W Wargin, K Patrick, C Kilts, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 184) with videos related to
Sort By:
Page
of 19
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1992
Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity
K B Johnson, H E Criswell, K F Jensen, et al.
Annals of Emergency Medicine
|
September 11, 1992
Selective aortic arch perfusion during cardiac arrest: a new resuscitation technique
J E Manning, C A Murphy, C M Hertz, et al.
Journal of Neurochemistry
|
November 1, 1987
Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression
S P Sivam, G R Breese, J E Krause, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1985
Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation
G E Duncan, I A Paul, T K Harden, et al.
Psychopharmacology
|
January 1, 1980
An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function
G D Frye, G R Breese, R B Mailman, et al.
Pharmacology, Biochemistry, and Behavior
|
September 1, 1984
Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome
G R Breese, A A Baumeister, T J McCown, et al.
Psychopharmacology
|
January 1, 1981
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity
M G Ondrusek, C D Kilts, G D Frye, et al.
Brain Research
|
April 14, 1978
Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons
R J Konkol, R B Mailman, E G Bendeich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1987
6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding
G R Breese, G E Duncan, T C Napier, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1983
Pharmacokinetics of methylphenidate in man, rat and monkey
W Wargin, K Patrick, C Kilts, et al.
Page
of 19